case 3: treatment after progression to mcrpc
Published 4 years ago • 73 plays • Length 7:52Download video MP4
Download video MP3
Similar videos
-
9:51
case 3: personalizing treatment for mcrpc
-
5:10
mcspc: treatment after progression on ar-targeted therapy
-
3:47
case 3: factors to consider in mcrpc treatment
-
1:46
os after progression on first novel hormonal therapy in mcspc vs mcrpc
-
4:35
support for continuing enzalutamide after mcrpc progression | axel merseburger
-
3:25
life expectancy with prostate cancer diagnosis
-
4:17
psa & hormone therapy for prostate cancer | ask a prostate expert, mark scholz, md
-
7:42
how to treat men with advanced castration resistant prostate cancer with ar directed therapy
-
1:22
cabazitaxel improves rpfs in patients with mcrpc
-
3:16
counseling patients with mcrpc
-
4:59
case of mhspca progressing to mcrpc
-
5:57
managing bone metastasis in patients with mcrpc
-
1:31
investigating prognostic markers for os with lupsma treatment in mcrpc
-
4:56
improving the prognosis for patients with mcrpc
-
0:45
treatment sequencing for metastatic castration-resistant prostate cancer
-
3:51
impressions of a patient with progression to mcrpc
-
4:21
case 3: clinical relevance of the ar-v7 biomarker in mcrpc
-
2:59
niraparib and abiraterone acetate for metastatic castration-resistant prostate cancer
-
2:16
testing the validity of a prognostic model for castration-resistant prostate cancer
-
8:56
case 3: use of radium-223 in mcrpc
-
3:09
mcrpc: sequencing therapy
-
4:18
case 3: treatment for fgfr3 bladder cancer